All In MedTech

Device Trial Radar · NCT02539056

The Post-marketing Surveillance to Evaluate the Efficacy and Safety of a CHONDRON (Autologous Cultured Chondrocyte)

This Post-marketing Surveillance to Evaluate the Efficacy and Safety of a CHONDRON (Autologous Cultured Chondrocyte) in Patients With Cartilage Defects in Their Knees.

Last checked: Nov 19, 2026Latest source record: Apr 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

22

Actual

Start

Oct 15, 2012

Primary completion

Mar 18, 2016

Study completion Mar 18, 2016

Sponsor

Lead sponsor
Cellontech Co., Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Sep 2, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 15 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A clinical trial to evaluate the long-term efficacy and safety of a CHONDRON (Autologous cultured Chondrocyte) for 48weeks, and additional 96weeks in patients with cartilage defects in their knees.

Conditions

  • Osteoarthritis
  • Traumatic Arthritis

Interventions

  • Chondron ImplantationDevice

    In one vial (0.4 ml), Main ingredient: 1.2 million or more autologous chondrocytes Culture solution: Adequate amount of Dulbecco's modified Eagle medium (DMEM) The cells that fill the vial are sufficiently suspended, and a sufficient amount of suspension is grafted in the defect with fibrin glue.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. change in pain of 100mm Visual Analog ScaleTime frame: 48 weeks after the surgery

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Inha Univerisity Hospital

    Incheon, Incheon, South Korea

  • Ewha Womans University Mokdong Hospital

    Seoul, Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.